179 related articles for article (PubMed ID: 16972974)
1. Safety and efficacy of blood glucose management practices at a diabetes camp.
Gunasekera H; Ambler G
J Paediatr Child Health; 2006 Oct; 42(10):643-8. PubMed ID: 16972974
[TBL] [Abstract][Full Text] [Related]
2. Insulin requirements and metabolic control in children with diabetes mellitus attending a summer camp.
Braatvedt GD; Mildenhall L; Patten C; Harris G
Diabet Med; 1997 Mar; 14(3):258-61. PubMed ID: 9088776
[TBL] [Abstract][Full Text] [Related]
3. Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart.
Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
Scand J Clin Lab Invest; 2008; 68(8):739-44. PubMed ID: 19016075
[TBL] [Abstract][Full Text] [Related]
4. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
[TBL] [Abstract][Full Text] [Related]
5. Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors.
Wiltshire EJ; Newton K; McTavish L
J Paediatr Child Health; 2006 Dec; 42(12):758-63. PubMed ID: 17096709
[TBL] [Abstract][Full Text] [Related]
6. Home blood-glucose monitoring: a new approach to the management of diabetes mellitus.
Cohen M; Zimmet PZ
Med J Aust; 1980 Dec; 2(13):713-6. PubMed ID: 7010095
[TBL] [Abstract][Full Text] [Related]
7. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
Meneghini L; Koenen C; Weng W; Selam JL
Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
[TBL] [Abstract][Full Text] [Related]
8. High day-to-day glucose variability: a frequent phenomenon in children and adolescents with type 1 diabetes attending summer camp.
Choleau C; Aubert C; Cahané M; Reach G
Diabetes Metab; 2008 Feb; 34(1):46-51. PubMed ID: 18206413
[TBL] [Abstract][Full Text] [Related]
9. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.
Laffel LM; Wentzell K; Loughlin C; Tovar A; Moltz K; Brink S
Diabet Med; 2006 Mar; 23(3):278-84. PubMed ID: 16492211
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
Wentholt IM; Maran A; Masurel N; Heine RJ; Hoekstra JB; DeVries JH
Diabet Med; 2007 May; 24(5):527-32. PubMed ID: 17381503
[TBL] [Abstract][Full Text] [Related]
11. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
[TBL] [Abstract][Full Text] [Related]
12. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
Khutsoane D; Sharma SK; Almustafa M; Jang HC; Azar ST; Danciulescu R; Shestakova M; Ayad NM; Guler S; Bech OM;
Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
[TBL] [Abstract][Full Text] [Related]
13. Cot-side electro-encephalography and interstitial glucose monitoring during insulin-induced hypoglycaemia in newborn lambs.
Harris DL; Battin MR; Williams CE; Weston PJ; Harding JE
Neonatology; 2009; 95(4):271-8. PubMed ID: 18984967
[TBL] [Abstract][Full Text] [Related]
14. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
15. [Our experience in continuous administration of insulin using infusion dispenser at a metabolic intensive care unit (MICU)].
Charvát J; Pálová S; Horácková M; Kratochvíl J; Masopust J
Vnitr Lek; 2007 Oct; 53(10):1047-52. PubMed ID: 18072428
[TBL] [Abstract][Full Text] [Related]
16. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.
Pfützner J; Forst T; Butzer R; Forst S; Weber MM; Pfützner AH; Pfützner A
Diabet Med; 2006 Oct; 23(10):1124-9. PubMed ID: 16978378
[TBL] [Abstract][Full Text] [Related]
17. Blood glucose levels in children with Type 1 diabetes attending a residential diabetes camp: a 2-year review.
Carlson KT; Carlson GW; Tolbert L; Demma LJ
Diabet Med; 2013 Mar; 30(3):e123-6. PubMed ID: 23157253
[TBL] [Abstract][Full Text] [Related]
18. A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients.
Mitchell I; Knight E; Gissane J; Tamhane R; Kolli R; Leditschke IA; Bellomo R; Finfer S;
Crit Care Resusc; 2006 Dec; 8(4):289-93. PubMed ID: 17227263
[TBL] [Abstract][Full Text] [Related]
19. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
